<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39400652</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-6014</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of epidemiology and global health</Title><ISOAbbreviation>J Epidemiol Glob Health</ISOAbbreviation></Journal><ArticleTitle>How a Novel Approach of Allergy Call Center Improved the Management of the Anti-COVID Vaccination Campaign in Piedmont: Italy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s44197-024-00309-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The anti-COVID vaccination campaign has led to a significant increase in the demand for allergology consultations in patients considered at risk of reaction to anti-COVID-19 vaccines. This study aims to describe the experience of the vaccination campaign held in Piedmont (Italy) which developed a new service of Allergy Call Center (ACC) thus providing for the screening and management of allergy high-risk patients during pandemic.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A retrospective analysis was performed on all patients considered at high risk for the development of allergic reactions who were referred by the Immunology and Allergy Unit of Azienda Ospedaliera Ordine Mauriziano in Turin, Italy, between December 2020 and December 2022 and also on ACC consultations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">During the COVID-19 pandemic, Piedmont Region instituted the ACC, active from May 10th, 2021 to December 31st 2022, to allow vaccinating doctors to require a telephonic consultation for patients who were considered at high risk for the development of allergic reactions. If further diagnostic evaluations were required, the ACC scheduled a visit with a Consultant of the Unit to better assess the clinical situation of the patient. Furthermore, patients referred by General Practitioners, Occupational Doctors and other consultants were also evaluated by the Unit when required.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the operational period the ACC received a total of 15,865 calls and referred only 336 patients to the unit (27.4% of the total referrals), while General Practitioners referred 499 patients (40.8%), Occupational Doctors referred 61 patients (4.9%), and other consultants referred 326 patients (26.6%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Evaluation and management of a large volume of requests seemed to be facilitated by a proactive framework for screening patients at high risk for allergic reactions as the ones referred by our ACC. This approach led to a prominent decrease in allergological visits to our tertiary care Centre, reducing the waiting times and providing additional support for both patients and healthcare providers, thus allowing the vaccinations to be more easily handled.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Badiu</LastName><ForeName>Iuliana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nicola</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy. stefania.nicola@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashidy</LastName><ForeName>Nicolò</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Mura</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarrini</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardi</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallicchio</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridolfi</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracco</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montabone</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzola</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Sardo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geronazzo</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comola</LastName><ForeName>Ludovica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apricena</LastName><ForeName>Antonietta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitali</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinternetto</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessi</LastName><ForeName>Lucrezia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meli</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boem</LastName><ForeName>Marzia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teocchi</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schinocca</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azzolina</LastName><ForeName>Maria Carmen Rita</ForeName><Initials>MCR</Initials><AffiliationInfo><Affiliation>Health Management, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negrini</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Clinical Immunology and Translational Medicine Unit, University of Genoa and IRCCS Ospedale Policlinico San Martino, Viale Benedetto XV, 6, 16132, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolla</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Borrelli</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brussino</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, 10128, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Epidemiol Glob Health</MedlineTA><NlmUniqueID>101592084</NlmUniqueID><ISSNLinking>2210-6006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allergy</Keyword><Keyword MajorTopicYN="N">Allergy call center</Keyword><Keyword MajorTopicYN="N">Allergy risk</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Consultations</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 vaccine</Keyword><Keyword MajorTopicYN="N">Vaccination campaign</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>11</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39400652</ArticleId><ArticleId IdType="doi">10.1007/s44197-024-00309-2</ArticleId><ArticleId IdType="pii">10.1007/s44197-024-00309-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>https://ourworldindata.org , accessed on December 20th, 2023.</Citation></Reference><Reference><Citation>Bianchi FP, Stefanizzi P, Brescia N, Lattanzio S, Martinelli A, Tafuri S. COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21(9):1289–300. https://doi.org/10.1080/14760584.2022.2093723 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2022.2093723</ArticleId><ArticleId IdType="pubmed">35757890</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46–51. https://doi.org/10.15585/mmwr.mm7002e1 .</Citation></Reference><Reference><Citation>Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. 2021;325(8):780–1. https://doi.org/10.1001/jama.2021.0600 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.0600</ArticleId><ArticleId IdType="pubmed">33475702</ArticleId><ArticleId IdType="pmc">8892260</ArticleId></ArticleIdList></Reference><Reference><Citation>Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021;384(7):643–9. https://doi.org/10.1056/NEJMra2035343 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2035343</ArticleId><ArticleId IdType="pubmed">33378605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng WH, Liu X, Mahalingam S. Development of vaccines for SARS-CoV-2. F1000Research. 2020. https://doi.org/10.12688/f1000research.25998.1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.25998.1</ArticleId><ArticleId IdType="pubmed">32850116</ArticleId><ArticleId IdType="pmc">7431966</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone CA Jr, Rukasin CRF, Beachkofsky TM, Phillips EJ. Immune-mediated adverse reactions to vaccines. Br J Clin Pharmacol. 2019;85(12):2694–706. https://doi.org/10.1111/bcp.14112 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.14112</ArticleId><ArticleId IdType="pubmed">31472022</ArticleId><ArticleId IdType="pmc">6955412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25–43. https://doi.org/10.1016/j.jaci.2012.04.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.04.003</ArticleId><ArticleId IdType="pubmed">22608573</ArticleId></ArticleIdList></Reference><Reference><Citation>Su JR, Moro PL, Ng CS, Lewis PW, Said MA, Cano MV. Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990–2016. J Allergy Clin Immunol. 2019;143(4):1465–73. https://doi.org/10.1016/j.jaci.2018.12.1003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.12.1003</ArticleId><ArticleId IdType="pubmed">30654049</ArticleId><ArticleId IdType="pmc">6580415</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.aaiito.it/news/linee-di-indirizzo-per-linquadramento-e-la-gestione-dei-pazienti-a-rischio-di-reazioni-allergiche-ai-vaccini-per-il-covid-19/</Citation></Reference><Reference><Citation>Sokolowska M, Eiwegger T, Ollert M, Torres MJ, Barber D, Del Giacco S, Jutel M, Nadeau KC, Palomares O, Rabin RL, Riggioni C, Vieths S, Agache I, Shamji MH. EAACI statement on the diag-nosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Allergy. 2021;76(6):1629–39. https://doi.org/10.1111/all.14739 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14739</ArticleId><ArticleId IdType="pubmed">33452689</ArticleId></ArticleIdList></Reference><Reference><Citation>Operational protocol for the Allergological risk of SARS-CoV2 vaccines developed by the Allergology and Immunology Unit of Azienda Ospedaliera Ordine Mauriziano in Turin protocol no. 2021/0157291 signed on April 29th 2021.</Citation></Reference><Reference><Citation>Lisi Aluma AD, Koulmini S, Kalilou S, Igweonu O, Kouassi AF, Traore MA, Ntezayabo B, De-layo LZ, Barry A, Esanga AM, Bagayoko AN, Mavungu Landu DJ, Kadai AA, Toyma B, Sedick DA, Nathei P, Mahamat D, Bohoussou P, Okeibunor J, de Medeiros N, Rabenarivo B, Dio-Mande F, Okiror S. Use of call centers in polio eradication efforts in island settlement in chad. J Immunol Sci. 2021;2:1113. https://doi.org/10.29245/2578-3009/2021/S2.1113 .</Citation><ArticleIdList><ArticleId IdType="doi">10.29245/2578-3009/2021/S2.1113</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldi JR, Kerns ME, O’Leary ST. Evidence-based strategies to increase vaccination uptake: a review. Curr Opin Pediatr. 2020;32(1):151–9. https://doi.org/10.1097/MOP.0000000000000843 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000843</ArticleId><ArticleId IdType="pubmed">31790027</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatman-Freedman A, Bromberg M, Ram A, Lutski M, Bassal R, Michailevich O, Saban M, Frankental D, Dichtiar R, Kruglikov-Moldavsky A, Rozani V, Karolinsky D, Braun T, Zuker I, Keinan-Boker L, Silverman BG. A COVID-19 call center for healthcare providers: dealing with rapidly evolving health policy guidelines. Isr J Health Policy Res. 2020;9(1):73. https://doi.org/10.1186/s13584-020-00433-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13584-020-00433-x</ArticleId><ArticleId IdType="pubmed">33267873</ArticleId><ArticleId IdType="pmc">7709808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng WH, Liu X, Mahalingam S. Development of vaccines for SARS-CoV-2. F1000Research. 2020;9:991.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.25998.1</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. COVID-19 Health system response monitor: What channels are countries using to communicate with the public and at what frequency? https://eurohealthobservatory.who.int/monitors/hsrm/analyses/hsrm/what-channels-are-countries-using-to-communicate-with-the-public-and-at-what-frequency [Last accessed 20 De-cember 2023].</Citation></Reference><Reference><Citation>https://www.who.int/news/item/17-05-2022-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness [Last accessed 20 December 2023].</Citation></Reference><Reference><Citation>US Centers for Disease Control and Prevention. CDC clinical call center. https://www.cdc.gov/coronavirus/2019-ncov/downloads/hcp/Clinician-On - Call-Center-508.pdf [last accessed 19 December 2023].</Citation></Reference><Reference><Citation>British Association of Dental Nurses. https://www.badn.org.uk/News/ COVID-19/NHS-helpline-for-healthcare-staff.aspx (last accessed 19 December 2023).</Citation></Reference><Reference><Citation>Bunn F, Byrne G, Kendall S. Telephone consultation and triage: effects on health care use and patient satisfaction. Cochrane Database Syst Rev. 2004;4:CD004180. https://doi.org/10.1002/14651858.CD004180.pub2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004180.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla SC, Pandit S, Soni D, Gogtay NJ. Evaluation of Allergic reactions following COVID - 19 vaccination in patients with documented allergies. J Assoc Phys India. 2021;69(10):11–2.</Citation></Reference><Reference><Citation>Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12(2):161–6. https://doi.org/10.1513/AnnalsATS.201410-459OC .</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201410-459OC</ArticleId><ArticleId IdType="pubmed">25569765</ArticleId><ArticleId IdType="pmc">4342835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>